1 / 6

TARE improves tumor response for HCC patients

TARE gives better disease control and improves quality of life of patients suffering from Hepatocellular Carcinoma<br>For more info-<br>https://nuclearmedicinetherapy.in/

6676
Télécharger la présentation

TARE improves tumor response for HCC patients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Transarterial Radioembolization (TARE) gives better disease control and improves quality of life of patients suffering from Hepatocellular Carcinoma.

  2. For Hepatocellular Carcinoma patients who cannot get a liver transplant done nor get the tumor operated upon, Transarterial Radioembolization (TARE) has proved to be an effective therapy. It can help extend lives from months to years.

  3. For Hepatocellular Carcinoma patients with inoperable tumors, Transarterial Radioembolization (TARE) can extend lives from months to years.

  4. TARE can be helpful for: Patients with unresectable HCC and a life expectancy of at least 3 months. Patients with HCC confined to the liver with tumor comprising less than 70% of the liver volume. Patients who are unsuitable for surgery or other modalities of treatment

  5. TARE is an emerging and promising therapy for the treatment of all stages of hepatocellular carcinoma from intermediate to advanced. It improves disease control & quality of life, has a better tolerability profile, a higher response rate and longer progression-free survival

  6. For more information on TARE do call us at +91 98111 27080, or write to us at info@nuclearmedicinetherapy.in or visit https://nuclearmedicinetherapy.in/.../transarterial... #TARE#NuclearMedicineTherapy#TransarterialRadioembolization#HepatocellularCarcinoma#NuclearMedicineCentre#FMRI

More Related